Donesta Bioscience Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Donesta Bioscience General Information

Description

Developer of estrogen hormone for treatment of women's health issues. The company is the developer of Estetrol, a natural estrogen appearing to have few side effects than previous natural and synthetic estrogens, with applications for hormone replacement therapy and oral contraceptive products.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Boslaan 11
  • 3701 CH Zeist
  • Netherlands
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Boslaan 11
  • 3701 CH Zeist
  • Netherlands

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Donesta Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Donesta Bioscience‘s full profile, request access.

Request a free trial

Donesta Bioscience Patents

Donesta Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-6447931-B2 Orally disintegrating solid unit dosage form containing estetrol component Active 12-Dec-2013
ES-2655076-T3 Solid dosing unit for oral disintegration with an estetrol component Active 12-Dec-2013
JP-2016540021-A Orally disintegrating solid unit dosage form containing estetrol component Active 12-Dec-2013
EP-3079671-A1 Orally disintegrating solid dosage unit containing an estetrol component Active 12-Dec-2013
EP-3079671-B1 Orally disintegrating solid dosage unit containing an estetrol component Active 12-Dec-2013 A61K31/565
To view Donesta Bioscience’s complete patent history, request access »

Donesta Bioscience Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Donesta Bioscience‘s full profile, request access.

Request a free trial

Donesta Bioscience FAQs

  • When was Donesta Bioscience founded?

    Donesta Bioscience was founded in 2011.

  • Where is Donesta Bioscience headquartered?

    Donesta Bioscience is headquartered in Zeist, Netherlands.

  • What industry is Donesta Bioscience in?

    Donesta Bioscience’s primary industry is Pharmaceuticals.

  • Is Donesta Bioscience a private or public company?

    Donesta Bioscience is a Private company.

  • What is the current valuation of Donesta Bioscience?

    The current valuation of Donesta Bioscience is .

  • What is Donesta Bioscience’s current revenue?

    The current revenue for Donesta Bioscience is .

  • Who are Donesta Bioscience’s investors?

    Pantarhei Bioscience has invested in Donesta Bioscience.

  • When was Donesta Bioscience acquired?

    Donesta Bioscience was acquired on 06-Apr-2015.

  • Who acquired Donesta Bioscience?

    Donesta Bioscience was acquired by Mithra Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »